(2-ETHOXY-BENZYL)-PYRIDIN-3-YLMETHYL-AMINE
|
- $200 - $874
- Product name: (2-ETHOXY-BENZYL)-PYRIDIN-3-YLMETHYL-AMINE
- CAS: 510723-56-5
- MF: C15H18N2O
- MW: 242.32
- EINECS:
- MDL Number:MFCD03724414
- Synonyms:(2-ETHOXY-BENZYL)-PYRIDIN-3-YLMETHYL-AMINE;3-Pyridinemethanamine, N-[(2-ethoxyphenyl)methyl]-
4 prices
Selected condition：
Brand
- American Custom Chemicals Corporation
- Crysdot
- Matrix Scientific
Package
- 500MG
- 1g
- 5g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0080699
- Product description(2-ETHOXY-BENZYL)-PYRIDIN-3-YLMETHYL-AMINE 95.00%
- Packaging500MG
- Price$768.08
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11113637
- Product descriptionN-(2-Ethoxybenzyl)-1-(pyridin-3-yl)methanamine 97%
- Packaging5g
- Price$874
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number010646
- Product description(2-Ethoxy-benzyl)-pyridin-3-ylmethyl-amine
- Packaging500mg
- Price$200
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number010646
- Product description(2-Ethoxy-benzyl)-pyridin-3-ylmethyl-amine
- Packaging1g
- Price$308
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| American Custom Chemicals Corporation | CHM0080699 | (2-ETHOXY-BENZYL)-PYRIDIN-3-YLMETHYL-AMINE 95.00% | 500MG | $768.08 | 2021-12-16 | Buy |
| Crysdot | CD11113637 | N-(2-Ethoxybenzyl)-1-(pyridin-3-yl)methanamine 97% | 5g | $874 | 2021-12-16 | Buy |
| Matrix Scientific | 010646 | (2-Ethoxy-benzyl)-pyridin-3-ylmethyl-amine | 500mg | $200 | 2021-12-16 | Buy |
| Matrix Scientific | 010646 | (2-Ethoxy-benzyl)-pyridin-3-ylmethyl-amine | 1g | $308 | 2021-12-16 | Buy |
Properties
Boiling point :372.0±27.0 °C(Predicted)
Density :1.074±0.06 g/cm3(Predicted)
pka :7.54±0.20(Predicted)
Density :1.074±0.06 g/cm3(Predicted)
pka :7.54±0.20(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|